Sequoia Financial Advisors LLC Purchases 1,444 Shares of Cameco Co. (NYSE:CCJ)

Sequoia Financial Advisors LLC increased its position in Cameco Co. (NYSE:CCJ) (TSE:CCO) by 1.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 75,520 shares of the basic materials company’s stock after buying an additional 1,444 shares during the period. Sequoia Financial Advisors LLC’s holdings in Cameco were worth $3,607,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Massachusetts Financial Services Co. MA purchased a new position in Cameco during the second quarter valued at $73,125,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in Cameco during the first quarter valued at approximately $31,131,000. King Luther Capital Management Corp purchased a new position in Cameco during the 2nd quarter valued at approximately $32,740,000. The Manufacturers Life Insurance Company raised its holdings in shares of Cameco by 28.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,987,526 shares of the basic materials company’s stock worth $97,653,000 after acquiring an additional 437,921 shares in the last quarter. Finally, Fred Alger Management LLC boosted its position in shares of Cameco by 106.2% during the 2nd quarter. Fred Alger Management LLC now owns 841,182 shares of the basic materials company’s stock valued at $41,386,000 after acquiring an additional 433,234 shares during the last quarter. 70.21% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Janney Montgomery Scott raised shares of Cameco to a “strong-buy” rating in a research note on Friday, October 4th. Scotiabank reduced their price objective on shares of Cameco from $81.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, August 19th. Glj Research restated a “buy” rating and set a $63.73 target price on shares of Cameco in a research report on Wednesday, August 14th. National Bank Financial upgraded Cameco to a “strong-buy” rating in a report on Tuesday, September 3rd. Finally, Bank of America lifted their target price on Cameco from $59.00 to $60.50 and gave the stock a “buy” rating in a research report on Wednesday, June 26th. One equities research analyst has rated the stock with a sell rating, five have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $66.56.

Cameco Price Performance

NYSE:CCJ opened at $54.08 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.48 and a current ratio of 3.22. The firm has a market cap of $23.53 billion, a price-to-earnings ratio of 138.67 and a beta of 0.90. The firm’s fifty day moving average is $45.43 and its two-hundred day moving average is $47.81. Cameco Co. has a one year low of $35.43 and a one year high of $58.72.

Cameco (NYSE:CCJ) (TSE:CCO) last released its quarterly earnings data on Wednesday, July 31st. The basic materials company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.14). Cameco had a net margin of 9.72% and a return on equity of 5.63%. The business had revenue of $598.00 million during the quarter, compared to analyst estimates of $756.00 million. During the same quarter in the prior year, the company posted ($0.01) earnings per share. The company’s revenue was up 24.1% on a year-over-year basis. Research analysts expect that Cameco Co. will post 0.83 EPS for the current year.

About Cameco

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.